NRIX position history
The shares of Nurix Therapeutics (NRIX) that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q4: 43,947 shares, $1.3M, <0.01% of portfolio, New
- 2022 Q1: 391,991 shares, $5.5M, 0.02% of portfolio, Add +792.0%
- 2022 Q2: 778,725 shares, $7.9M, 0.05% of portfolio, Add +98.7%
- 2022 Q3: 1,286,522 shares, $17M, 0.12% of portfolio, Add +65.2%
- 2022 Q4: 1,988,254 shares, $22M, 0.19% of portfolio, Add +54.5%
- 2023 Q1: 2,239,859 shares, $20M, 0.14% of portfolio, Add +12.7%
- 2023 Q2: 2,261,071 shares, $23M, 0.15% of portfolio, Add +0.9%
- 2023 Q3: 2,593,047 shares, $20M, 0.16% of portfolio, Add +14.7%
- 2023 Q4: 3,194,999 shares, $33M, 0.20% of portfolio, Add +23.2%
- 2024 Q1: 2,635,338 shares, $39M, 0.27% of portfolio, Reduce −17.5%
- 2024 Q2: 2,323,332 shares, $48M, 0.43% of portfolio, Reduce −11.8%
- 2024 Q3: 2,216,365 shares, $50M, 0.46% of portfolio, Reduce −4.6%
- 2024 Q4: 1,530,293 shares, $29M, 0.24% of portfolio, Reduce −31.0%
- 2025 Q1: 1,590,910 shares, $19M, 0.19% of portfolio, Add +4.0%
- 2025 Q2: 1,575,032 shares, $18M, 0.13% of portfolio, Reduce −1.0%
- 2025 Q3: 1,510,404 shares, $14M, 0.08% of portfolio, Reduce −4.1%
- 2025 Q4: 1,602,539 shares, $30M, 0.20% of portfolio, Add +6.1%
- 2026 Q1: 1,721,135 shares, $27M, 0.21% of portfolio, Add +7.4%
- 2026 Q2: 1,793,196 shares, $44M, 0.28% of portfolio, Add +4.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|